Mergers & AcquisitionsMedium•18 November 2026•
1 min read
Challenger Rejects Revised $4.4B Daiichi Life Takeover Bid
Key Facts
1Challenger's board rejected a revised takeover offer of $12.20 per share from its largest shareholder, TAL Daiichi Life Australia.
2The new proposal is 40 cents higher than the previous $11.80 bid that was rejected in October.
Challenger's board rejected a revised takeover offer of $12.20 per share from its largest shareholder, TAL Daiichi Life Australia. The new proposal represents a 40-cent increase over the previous $11.80 bid that was rejected in October.
The company stated that the sweetened offer does not adequately represent fair value for shareholders in the context of a control transaction, following discussions between the two firms. This rejection comes as Australian markets prepare for key macroeconomic data, with employment change and unemployment rate figures scheduled for release on November 19, 2026.